Aventiv Research, Inc.

Summary

Aventiv Research, Inc. is a medical facility located in Columbus, Ohio. This center is recognized for care of Type 2 Diabetes, I Am A Healthy Volunteer, Diabetes, COVID-19, Osteoarthritis and other specialties. Aventiv Research, Inc. is involved with conducting 225 clinical trials across 250 conditions. There are 5 research doctors associated with this hospital, such as Andrew W. Pippas, Samir Arora, MD, Sridhar Guduri, MD, and Kenneth R Boren.

Top PIs

Clinical Trials running at Aventiv Research, Inc.

Diabetes

COVID-19

Foot Ulcer

Atopic Dermatitis

Medical Device Dermatitis

I Am A Healthy Volunteer

Idiopathic Short Stature

Hidradenitis Suppurativa

Liver Fibrosis

Fatty Liver Disease

ENERGI-F703 GEL

for Diabetic Foot Ulcers

This trial is testing a special gel called ENERGI-F703 GEL to see if it can help heal foot ulcers in people with diabetes. The study focuses on patients with mild to moderate diabetic foot ulcers. The gel works by creating a good environment for skin repair and protecting the wound from germs. ENERGI-F703 gel, containing adenine as its active ingredient, has shown promise in accelerating wound healing in diabetic mice.

Recruiting

1 award

Phase 3

7 criteria

SAR442970

for Type 1 Diabetes

This is a randomized, placebo-controlled, parallel group, multicenter, double-blind Phase 2a, 2-arm study. The goal of this Phase 2a study is to assess safety and efficacy of SAR442970 in comparison to placebo to preserve β-cell function in participants with recently diagnosed type 1 diabetes (T1D) on insulin therapy. The study design comprises 2 parts: in Part A adult participants (18 to 35 years of age at screening) and in Part B adolescent and young adult participants (age range 12 to 21 years) will be randomized into SAR442970 and placebo groups. Approximately 84 participants will be included with randomization ratio 3:1 (active:placebo). The study includes a screening period (3 to 5 weeks), a double-blind treatment period of 52 weeks and a safety follow-up of 26 weeks.

Recruiting

0 awards

Phase 2

2 criteria